Launer LJ - Search Results

1

Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.

Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Petanceska S, Browne P, Wassar D, Johnson-Traver S, Lochhead J, Ziolkowski C. Sparks DL, et al. Among authors: launer lj. Curr Alzheimer Res. 2005 Jul;2(3):343-53. doi: 10.2174/1567205054367900. Curr Alzheimer Res. 2005. PMID: 15974900 Clinical Trial.

2

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Browne P, Wasser D, Johnson-Traver S, Lochhead J, Ziolwolski C. Sparks DL, et al. Among authors: launer lj. Arch Neurol. 2005 May;62(5):753-7. doi: 10.1001/archneur.62.5.753. Arch Neurol. 2005. PMID: 15883262 Clinical Trial.

3

Next steps in Alzheimer's disease research: interaction between epidemiology and basic science.

Launer LJ. Launer LJ. Curr Alzheimer Res. 2007 Apr;4(2):141-3. doi: 10.2174/156720507780362155. Curr Alzheimer Res. 2007. PMID: 17430237

4

Prevention of AD: the which, when, and on whom?

Launer LJ. Launer LJ. Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3 Suppl 2):S75-8. doi: 10.1097/00002093-200607001-00011. Alzheimer Dis Assoc Disord. 2006. PMID: 16917200 Review. No abstract available.

5

Prognosis of Alzheimer's disease: the Rotterdam Study.

Ruitenberg A, Kalmijn S, de Ridder MA, Redekop WK, van Harskamp F, Hofman A, Launer LJ, Breteler MM. Ruitenberg A, et al. Among authors: launer lj. Neuroepidemiology. 2001 Aug;20(3):188-95. doi: 10.1159/000054786. Neuroepidemiology. 2001. PMID: 11490165

6

Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A. Launer LJ, et al. Neurology. 1999 Jan 1;52(1):78-84. doi: 10.1212/wnl.52.1.78. Neurology. 1999. PMID: 9921852

7

Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment.

Visser PJ, Scheltens P, Verhey FR, Schmand B, Launer LJ, Jolles J, Jonker C. Visser PJ, et al. Among authors: launer lj. J Neurol. 1999 Jun;246(6):477-85. doi: 10.1007/s004150050387. J Neurol. 1999. PMID: 10431775

8

Effect of smoking on global cognitive function in nondemented elderly.

Ott A, Andersen K, Dewey ME, Letenneur L, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A, Launer LJ; EURODEM Incidence Research Group. Ott A, et al. Among authors: launer lj. Neurology. 2004 Mar 23;62(6):920-4. doi: 10.1212/01.wnl.0000115110.35610.80. Neurology. 2004. PMID: 15037693

9

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study.

Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MM, Hofman A. Andersen K, et al. Among authors: launer lj. Neurology. 1995 Aug;45(8):1441-5. doi: 10.1212/wnl.45.8.1441. Neurology. 1995. PMID: 7644037

10

Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.

Jonker C, Schmand B, Lindeboom J, Havekes LM, Launer LJ. Jonker C, et al. Among authors: launer lj. Arch Neurol. 1998 Aug;55(8):1065-9. doi: 10.1001/archneur.55.8.1065. Arch Neurol. 1998. PMID: 9708956

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

813 results

Search Page